Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for PODD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 948.40M
March 31, 2026 948.10M
December 31, 2025 998.10M
September 30, 2025 1.015B
June 30, 2025 1.400B
March 31, 2025 1.695B
December 31, 2024 1.420B
September 30, 2024 1.398B
June 30, 2024 1.398B
March 31, 2024 1.402B
December 31, 2023 1.445B
September 30, 2023 1.420B
June 30, 2023 1.398B
March 31, 2023 1.397B
December 31, 2022 1.429B
September 30, 2022 1.407B
June 30, 2022 1.412B
March 31, 2022 1.416B
December 31, 2021 1.282B
September 30, 2021 1.286B
June 30, 2021 1.256B
March 31, 2021 1.067B
December 31, 2020 1.071B
September 30, 2020 921.50M
June 30, 2020 910.20M
Date Value
March 31, 2020 899.00M
December 31, 2019 902.30M
September 30, 2019 997.32M
June 30, 2019 614.85M
March 31, 2019 607.48M
December 31, 2018 591.98M
September 30, 2018 584.48M
June 30, 2018 577.12M
March 31, 2018 573.33M
December 31, 2017 566.17M
September 30, 2017 344.95M
June 30, 2017 340.84M
March 31, 2017 336.76M
December 31, 2016 333.04M
September 30, 2016 330.02M
June 30, 2016 178.00M
March 31, 2016 178.13M
December 31, 2015 177.49M
September 30, 2015 180.95M
June 30, 2015 180.77M
March 31, 2015 180.56M
December 31, 2014 174.64M
September 30, 2014 174.50M
June 30, 2014 201.47M
March 31, 2014 123.69M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 32.61B
DexCom, Inc. 1.378B
Boston Scientific Corp. 12.62B
PROCEPT BioRobotics Corp. 75.00M
Globus Medical, Inc. 97.53M